Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
00:06:37 EST Sun 08 Feb 2026
Enter Symbol
or Name
USA
CA



Q:TRIB - TRINITY BIOTECH PLC SPON ADR EACH REP 20 ORD (POST SPLIT) - Website unknown - click to update
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
TRIB - Q0.10.7134·1.0550.00.80+0.092413.1155.21013070.71  0.80  0.7033.44  0.4819:09:57Dec 2315 min RT 2¢

Recent Trades - Last 10 of 307
Time ETExPriceChangeVolume
19:09:57Q0.78110.0735100
19:07:53Q0.79990.09231,000
18:52:59Q0.7810.0734100
18:27:22Q0.79990.0923175
18:20:27Q0.7810.07342,152
17:49:06Q0.780.072440
17:10:38Q0.79910.091528
16:00:01Q0.800.092413
16:00:01Q0.800.092414
16:00:01Q0.800.092416

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolTypeHeadline
2025-12-23 08:50U:TRIBNews ReleaseTrinity Biotech Announces Agreements to Strengthen Capital Structure and Support Growth Initiatives
2025-12-23 07:32U:TRIBNews ReleaseTrinity Biotech Awarded a Major Order for 9 Million TrinScreen HIV Tests
2025-12-15 09:15U:TRIBNews ReleaseTrinity Biotech Expands Global Rollout of High-Capacity Column System for FDA-Cleared HbA1c Testing Solution After Securing Regulatory Clearances
2025-11-18 09:00U:TRIBNews ReleaseTrinity Biotech Secures Major Regulatory Approval for Offshored and Outsourced Manufacturing of Its Market Leading Uni-Gold Rapid HIV Test, Further Accelerating Financial Performance Transformation
2025-11-14 09:00U:TRIBNews ReleaseTrinity Biotech Announces Collaboration to Advance Epigenetic Analysis for EpiCapture Prostate Cancer Test
2025-10-27 09:00U:TRIBNews ReleaseTrinity Biotech Welcomes Perceptive Advisor's Indication of Potential Debt-to-Equity Conversion - Strengthening Balance Sheet and Supporting Growth
2025-09-02 09:30U:TRIBNews ReleaseTrinity Biotech Regains Compliance with Nasdaq Listing Requirements
2025-08-21 09:00U:TRIBNews ReleaseTrinity Biotech Appoints Paul Tivnan as Non-Executive Director
2025-08-20 09:01U:TRIBNews ReleaseRegulatory Approval Granted for Commencement of Trinity Biotech's Offshored and Outsourced Manufacturing of its Flagship Rapid HIV Test, Facilitating Strategic and Financial Performance Transformation
2025-08-14 09:00U:TRIBNews ReleaseTrinity Biotech Receives Regulatory Approval to Begin FDA-Cleared PreClara(TM) Preeclampsia Testing Service
2025-08-12 08:45U:TRIBNews ReleaseTrinity Biotech Achieves Breakthrough Clinical Trial Results for Redesigned CGM Sensor
2025-08-07 08:01U:TRIBNews ReleaseTrinity Biotech Announces Launch of FDA-cleared Preeclampsia Testing Service
2025-07-24 08:20U:TRIBNews ReleaseTrinity Biotech Unveils CGM+: An AI-Native Platform Targeting the $260 Billion AI Wearable Market
2025-07-01 09:00U:TRIBNews ReleaseTrinity Biotech Reaches Profitability Inflection Point, Marking Major Milestone in Strategic Turnaround
2025-06-24 08:01U:TRIBNews ReleaseTrinity Biotech Secures Key Regulatory Approval for Offshored and Outsourced Manufacturing of Its Flagship Rapid HIV Test, Accelerating Strategic & Financial Performance Transformation
2025-05-15 16:01U:TRIBNews ReleaseTrinity Biotech Publishes Fourth Quarter and Fiscal Year 2024 Financial Results & Provides a Business Update
2025-03-14 16:30U:TRIBNews ReleaseTrinity Biotech Receives Non-Compliance Notice Regarding Nasdaq Global Select Requirement for Minimum Market Value of Publicly Held Shares and Nasdaq Minimum Bid Price Requirement
2025-03-13 07:30U:TRIBNews ReleaseTrinity Biotech Further Strengthens Focus on Continuous Glucose Monitoring - Appoints Barclays to Advise on Ongoing Strategic Realignment Process
2025-02-28 08:30U:TRIBNews ReleaseTrinity Biotech Announces Additional Funding To Support Transformation Plan & Continued Development of the Company's Continuous Glucose Monitoring Technology